Loading…
Sunil Healthcare (BSE 537253)₹70.50+0.40%Pharmaceuticals
Sunil Healthcare is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 20.0 against a peer median of 20.0, and ROCE of 6.5% against a peer median of 6.5%, and latest-quarter sales growth of −16.2% against a peer median of 11.4%. By market cap it is #8 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Denis Chem Lab | 83 | 10.0 | 14.0 | 9.6 | 0.05 | 2.5 | 182 | 8 | 13.1 | −43.1 | vs BSE 537253 |
| Vilin Bio Med | 83 | 43.3 | 10.8 | 7.5 | 0.01 | 0.0 | 42 | 2 | 215.6 | 1,866.7 | vs BSE 537253 |
| Rekvina Labs | 81 | — | −333.3 | — | — | 0.0 | 1 | −0 | — | — | vs BSE 537253 |
| Samrat Pharmachem | 80 | — | −3.0 | −4.8 | 0.16 | 0.4 | 289 | −3 | 0.7 | — | vs BSE 537253 |
| Shelter Pharma | 76 | 8.3 | 20.4 | 15.1 | 0.01 | 0.8 | 73 | 9 | 49.8 | 22.2 | vs BSE 537253 |
| Source Natural Foods & Herbal Supplements | 75 | 22.0 | — | — | — | 0.0 | 71 | 3 | 76.3 | 7.8 | vs BSE 537253 |
| Vineet Laboratories | 73 | — | −28.0 | −89.5 | 2.99 | 0.0 | 75 | −20 | −13.5 | — | vs BSE 537253 |
| Sunil Healthcare | 72 | 20.0 | 6.5 | 6.0 | 0.80 | 0.0 | 87 | 4 | −16.2 | −50.0 | — |
| Sunil Healthcare | 72 | 20.3 | 6.5 | 6.1 | 0.85 | 0.0 | 87 | 4 | −16.1 | −48.9 | vs BSE 537253 |
| Zenith Drugs | 68 | 17.1 | 9.1 | 5.8 | 0.73 | 0.0 | 170 | 4 | 40.8 | 99.0 | vs BSE 537253 |
| Onyx Biotec | 62 | — | 1.1 | −0.4 | 0.27 | 0.0 | 69 | −0 | 9.8 | −64.6 | vs BSE 537253 |
| Peer median | 75 | 20.0 | 6.5 | 6.0 | 0.27 | 0.0 | 75 | 3 | 11.4 | −17.6 |
Listed companies closest to Sunil Healthcare in Pharmaceuticals include Denis Chem Lab, Vilin Bio Med, Rekvina Labs, Samrat Pharmachem, Shelter Pharma, Source Natural Foods & Herbal Supplements, Vineet Laboratories, Sunil Healthcare.
Denis Chem Lab, with a market cap of ₹83.33 Cr.
Sunil Healthcare trades at a P/E of 20.0; the median of its peer set is 20.0. A P/E above or below the median is a description, not a judgement on value.
Sunil Healthcare's return on capital employed is 6.5%, above the peer median of 6.5%.